Company / Net Debt per Share
Corbus Pharmaceuticals Holdings, Inc. Net Debt per Share History
FY2020-FY2022 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Debt per Share
-$0.24
FY2022
5-year range
-$1.04 / -$0.09
FY2020-FY2022
Trend
-157.6%
vs FY2021
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Increased from $-1.04 to $-0.24 over the past 2 years.
Based on SEC 10-K filings.
-0.24 in FY2022.
Increased from $-1.04 to $-0.24 over the past 2 years.
Net Debt per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2022, net debt per share decreased 157.6% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -12.48 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net Debt per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2022 | -$0.24 | -157.6% |
| FY2021 | -$0.09 | +90.9% |
| FY2020 | -$1.04 | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | - | - |
| FY2015 | - | - |
As of FY2022 · SEC 10-K · Updated Jun 24, 2026